ATS Blue Journal
@atsblueeditor.bsky.social
Posting content from the American Journal of Respiratory and Critical Care Medicine; follows do not indicate endorsement.
#pulmCC #sleepmed #AJRCCM #RespEd #ATS #medsky
https://www.atsjournals.org/journal/ajrccm
#pulmCC #sleepmed #AJRCCM #RespEd #ATS #medsky
https://www.atsjournals.org/journal/ajrccm
Pinned
📣 Call for Papers! 📣
Looking for articles highlighting the spectrum of discovery in sleep-disordered breathing
📅 Deadline: July 1, 2026
🔬Learn More: tinyurl.com/fxsd2b9d
🖱️Submit here: tinyurl.com/3h7dmm2x
@srpatel.bsky.social @ats-srn.bsky.social @atscommunity.bsky.social #medsky
Looking for articles highlighting the spectrum of discovery in sleep-disordered breathing
📅 Deadline: July 1, 2026
🔬Learn More: tinyurl.com/fxsd2b9d
🖱️Submit here: tinyurl.com/3h7dmm2x
@srpatel.bsky.social @ats-srn.bsky.social @atscommunity.bsky.social #medsky
The Blue Journal thanks Barbara Jones, MD, MS, for her contribution to the January issue
Diagnosis and Management of Community-acquired Pneumonia: An Official American Thoracic Society Clinical Practice Guideline
academic.oup.com/ajrccm/artic...
Diagnosis and Management of Community-acquired Pneumonia: An Official American Thoracic Society Clinical Practice Guideline
academic.oup.com/ajrccm/artic...
February 9, 2026 at 4:40 PM
The Blue Journal thanks Barbara Jones, MD, MS, for her contribution to the January issue
Diagnosis and Management of Community-acquired Pneumonia: An Official American Thoracic Society Clinical Practice Guideline
academic.oup.com/ajrccm/artic...
Diagnosis and Management of Community-acquired Pneumonia: An Official American Thoracic Society Clinical Practice Guideline
academic.oup.com/ajrccm/artic...
Connecting the dots between the epigenome, Th2 immunity, and airway hyperreactivity
@atscommunity.bsky.social #medsky
🔓 Open Access
🔗 tinyurl.com/mr42cryk
@atscommunity.bsky.social #medsky
🔓 Open Access
🔗 tinyurl.com/mr42cryk
February 9, 2026 at 3:10 PM
Connecting the dots between the epigenome, Th2 immunity, and airway hyperreactivity
@atscommunity.bsky.social #medsky
🔓 Open Access
🔗 tinyurl.com/mr42cryk
@atscommunity.bsky.social #medsky
🔓 Open Access
🔗 tinyurl.com/mr42cryk
The latest issue of the #AJRCCM is now live!
Take a look: academic.oup.com/ajrccm/issue...
@atscommunity.bsky.social #medsky
Take a look: academic.oup.com/ajrccm/issue...
@atscommunity.bsky.social #medsky
February 9, 2026 at 3:00 PM
The latest issue of the #AJRCCM is now live!
Take a look: academic.oup.com/ajrccm/issue...
@atscommunity.bsky.social #medsky
Take a look: academic.oup.com/ajrccm/issue...
@atscommunity.bsky.social #medsky
The Blue Journal thanks Mattia Nigro, MD, for his contribution to the January issue
Positioning Dipeptidyl Peptidase-1 Inhibitors in Bronchiectasis: No Drug Is an Island
academic.oup.com/ajrccm/artic...
Positioning Dipeptidyl Peptidase-1 Inhibitors in Bronchiectasis: No Drug Is an Island
academic.oup.com/ajrccm/artic...
February 9, 2026 at 2:55 PM
The Blue Journal thanks Mattia Nigro, MD, for his contribution to the January issue
Positioning Dipeptidyl Peptidase-1 Inhibitors in Bronchiectasis: No Drug Is an Island
academic.oup.com/ajrccm/artic...
Positioning Dipeptidyl Peptidase-1 Inhibitors in Bronchiectasis: No Drug Is an Island
academic.oup.com/ajrccm/artic...
February 6, 2026 at 7:44 PM
🎙️ Just published a new episode of Out of the Blue: An AJRCCM Podcast: Host-Microbe Multiomic Profiling Predicts Mortality in Sepsis.
🎧 Listen here: outoftheblue.transistor.fm/episodes/hos...
@atscommunity.bsky.social #medsky
🎧 Listen here: outoftheblue.transistor.fm/episodes/hos...
@atscommunity.bsky.social #medsky
Out of the Blue: An AJRCCM Podcast | Host-Microbe Multiomic Profiling Predicts Mortality in Sepsis
Dr. Michael Lanspa chats with Dr. Natasha Spottiswoode and Chaz Langelier about their article,
outoftheblue.transistor.fm
February 5, 2026 at 5:44 PM
🎙️ Just published a new episode of Out of the Blue: An AJRCCM Podcast: Host-Microbe Multiomic Profiling Predicts Mortality in Sepsis.
🎧 Listen here: outoftheblue.transistor.fm/episodes/hos...
@atscommunity.bsky.social #medsky
🎧 Listen here: outoftheblue.transistor.fm/episodes/hos...
@atscommunity.bsky.social #medsky
📣 Call for Papers! 📣
Looking for articles highlighting the spectrum of discovery in sleep-disordered breathing
📅 Deadline: July 1, 2026
🔬Learn More: tinyurl.com/fxsd2b9d
🖱️Submit here: tinyurl.com/3h7dmm2x
@srpatel.bsky.social @ats-srn.bsky.social @atscommunity.bsky.social #medsky
Looking for articles highlighting the spectrum of discovery in sleep-disordered breathing
📅 Deadline: July 1, 2026
🔬Learn More: tinyurl.com/fxsd2b9d
🖱️Submit here: tinyurl.com/3h7dmm2x
@srpatel.bsky.social @ats-srn.bsky.social @atscommunity.bsky.social #medsky
February 5, 2026 at 5:35 PM
📣 Call for Papers! 📣
Looking for articles highlighting the spectrum of discovery in sleep-disordered breathing
📅 Deadline: July 1, 2026
🔬Learn More: tinyurl.com/fxsd2b9d
🖱️Submit here: tinyurl.com/3h7dmm2x
@srpatel.bsky.social @ats-srn.bsky.social @atscommunity.bsky.social #medsky
Looking for articles highlighting the spectrum of discovery in sleep-disordered breathing
📅 Deadline: July 1, 2026
🔬Learn More: tinyurl.com/fxsd2b9d
🖱️Submit here: tinyurl.com/3h7dmm2x
@srpatel.bsky.social @ats-srn.bsky.social @atscommunity.bsky.social #medsky
Reposted by ATS Blue Journal
When it comes to respiratory health, early abnormalities should be taken seriously. As Anna Podolanczuk, MD, explains on the ATS Breathe Easy podcast, early intervention could help patient outcomes with it comes to interstitial lung disease.
Watch now: youtu.be/S7-_yt76M_k
Watch now: youtu.be/S7-_yt76M_k
February 3, 2026 at 4:30 PM
When it comes to respiratory health, early abnormalities should be taken seriously. As Anna Podolanczuk, MD, explains on the ATS Breathe Easy podcast, early intervention could help patient outcomes with it comes to interstitial lung disease.
Watch now: youtu.be/S7-_yt76M_k
Watch now: youtu.be/S7-_yt76M_k
Reposted by ATS Blue Journal
📣 Call for Papers! 📣
Looking for articles highlighting the spectrum of discovery in sleep-disordered breathing
📅 Deadline: July 1, 2026
🔬Learn More: tinyurl.com/fxsd2b9d
🖱️Submit here: tinyurl.com/3h7dmm2x
@srpatel.bsky.social @ats-srn.bsky.social @atscommunity.bsky.social #medsky
Looking for articles highlighting the spectrum of discovery in sleep-disordered breathing
📅 Deadline: July 1, 2026
🔬Learn More: tinyurl.com/fxsd2b9d
🖱️Submit here: tinyurl.com/3h7dmm2x
@srpatel.bsky.social @ats-srn.bsky.social @atscommunity.bsky.social #medsky
January 21, 2026 at 5:25 PM
📣 Call for Papers! 📣
Looking for articles highlighting the spectrum of discovery in sleep-disordered breathing
📅 Deadline: July 1, 2026
🔬Learn More: tinyurl.com/fxsd2b9d
🖱️Submit here: tinyurl.com/3h7dmm2x
@srpatel.bsky.social @ats-srn.bsky.social @atscommunity.bsky.social #medsky
Looking for articles highlighting the spectrum of discovery in sleep-disordered breathing
📅 Deadline: July 1, 2026
🔬Learn More: tinyurl.com/fxsd2b9d
🖱️Submit here: tinyurl.com/3h7dmm2x
@srpatel.bsky.social @ats-srn.bsky.social @atscommunity.bsky.social #medsky
Addressing the Global Challenges of COPD and Asthma: A Shared Vision from GOLD and GINA
There are global challenges regarding the prevention, diagnosis, and management of COPD and asthma. GOLD and GINA commit to work together to address them
🔗 tinyurl.com/55hu2z3t
There are global challenges regarding the prevention, diagnosis, and management of COPD and asthma. GOLD and GINA commit to work together to address them
🔗 tinyurl.com/55hu2z3t
Addressing the global challenges of chronic obstructive pulmonary disease and asthma: a shared vision from the Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) and the Global Initiat...
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) and Global Initiative for Asthma (GINA) have produced strategy reports and recommendation
tinyurl.com
January 29, 2026 at 9:10 PM
Addressing the Global Challenges of COPD and Asthma: A Shared Vision from GOLD and GINA
There are global challenges regarding the prevention, diagnosis, and management of COPD and asthma. GOLD and GINA commit to work together to address them
🔗 tinyurl.com/55hu2z3t
There are global challenges regarding the prevention, diagnosis, and management of COPD and asthma. GOLD and GINA commit to work together to address them
🔗 tinyurl.com/55hu2z3t
This Out of the Blue podcast explores how inhaled textile microplastic fibers may affect airway development and lung health.
🎧 Listen here: share.transistor.fm/s/975fe848
@atscommunity.bsky.social #medsky
🎧 Listen here: share.transistor.fm/s/975fe848
@atscommunity.bsky.social #medsky
Inhalable Textile Microplastic Fibers Impair Airway Epithelial Differentiation and Inhaled Microplastics and Airway Development: Concerning Evidence from Organoids | Out of the Blue: An AJRCCM Podcas...
Dr. John Fleetham chats with Dr. Barbro N Melgert and Dr. Chris Carlsten about their articles, "Inhalable Textile Microplastic Fibers Impair Airway Epithelial Differentiation" and "Inhaled Microplasti...
share.transistor.fm
January 29, 2026 at 5:18 PM
This Out of the Blue podcast explores how inhaled textile microplastic fibers may affect airway development and lung health.
🎧 Listen here: share.transistor.fm/s/975fe848
@atscommunity.bsky.social #medsky
🎧 Listen here: share.transistor.fm/s/975fe848
@atscommunity.bsky.social #medsky
Reposted by ATS Blue Journal
A good night's sleep can affect more than just your energy levels. As Mio Kobayashi Frisk, MD, explains on the ATS Breathe Easy podcast, sleep disorders like insomnia and sleep apnea often lead to uncontrolled hypertension, even without other risk factors.
Watch now: youtu.be/38FMYrVzQaA
Watch now: youtu.be/38FMYrVzQaA
January 27, 2026 at 5:00 PM
A good night's sleep can affect more than just your energy levels. As Mio Kobayashi Frisk, MD, explains on the ATS Breathe Easy podcast, sleep disorders like insomnia and sleep apnea often lead to uncontrolled hypertension, even without other risk factors.
Watch now: youtu.be/38FMYrVzQaA
Watch now: youtu.be/38FMYrVzQaA
📣 Wed, Jan 28th at 11am ET!
Bronchiectasis Education Center: Ask the Expert with Anne O’Donnell, MD
Join leading expert, Ashley Losier, MD, from Yale University, for an interactive “Ask the Expert” session on bronchiectasis at 1 p.m. ET on January 28, 2026.
Registration is required and is free – https://ow.ly/1Bcs50XWGES
Join leading expert, Ashley Losier, MD, from Yale University, for an interactive “Ask the Expert” session on bronchiectasis at 1 p.m. ET on January 28, 2026.
Registration is required and is free – https://ow.ly/1Bcs50XWGES
January 26, 2026 at 10:14 PM
📣 Wed, Jan 28th at 11am ET!
📣 We are pleased to inform you that all accepted ahead-of-print articles are now available at academic.oup.com/ajrccm/advan...
@atscommunity.bsky.social #medsky
@atscommunity.bsky.social #medsky
Advance articles | American Journal of Respiratory and Critical Care Medicine | Oxford Academic
academic.oup.com
January 23, 2026 at 2:33 PM
📣 We are pleased to inform you that all accepted ahead-of-print articles are now available at academic.oup.com/ajrccm/advan...
@atscommunity.bsky.social #medsky
@atscommunity.bsky.social #medsky
Reposted by ATS Blue Journal
📣The ATS Steering Committee on Advancement & Learning (SCALe) has opportunities for ATS members to grow your network. Apply to strengthen your #professionaldevelopment and shape future educational initiatives at the ATS.🥼Deadline: 5 p.m. ET, Jan. 28 1️⃣/2️⃣8️⃣
Apply now: site.thoracic.org/learning/ste...
Apply now: site.thoracic.org/learning/ste...
January 22, 2026 at 5:00 PM
📣The ATS Steering Committee on Advancement & Learning (SCALe) has opportunities for ATS members to grow your network. Apply to strengthen your #professionaldevelopment and shape future educational initiatives at the ATS.🥼Deadline: 5 p.m. ET, Jan. 28 1️⃣/2️⃣8️⃣
Apply now: site.thoracic.org/learning/ste...
Apply now: site.thoracic.org/learning/ste...
🏆 HIGHLIGHTING AJRCCM MOST-READ ARTICLES OF 2025
Is Disease Stability an Attainable Chronic Obstructive Pulmonary Disease Treatment Goal?
@atscommunity.bsky.social #medsky
🔗 tinyurl.com/3npjrbx5
Is Disease Stability an Attainable Chronic Obstructive Pulmonary Disease Treatment Goal?
@atscommunity.bsky.social #medsky
🔗 tinyurl.com/3npjrbx5
Is Disease Stability an Attainable Chronic Obstructive Pulmonary Disease Treatment Goal? | American Journal of Respiratory and Critical Care Medicine
www.atsjournals.org
January 22, 2026 at 5:32 PM
🏆 HIGHLIGHTING AJRCCM MOST-READ ARTICLES OF 2025
Is Disease Stability an Attainable Chronic Obstructive Pulmonary Disease Treatment Goal?
@atscommunity.bsky.social #medsky
🔗 tinyurl.com/3npjrbx5
Is Disease Stability an Attainable Chronic Obstructive Pulmonary Disease Treatment Goal?
@atscommunity.bsky.social #medsky
🔗 tinyurl.com/3npjrbx5
🏆 HIGHLIGHTING AJRCCM MOST-READ ARTICLES OF 2025
Extended Continuous Positive Airway Pressure in Preterm Infants Increases Lung Growth at 6 Months: A Randomized Controlled Trial
@atscommunity.bsky.social #medsky
🔗 tinyurl.com/pdzbkekd
Extended Continuous Positive Airway Pressure in Preterm Infants Increases Lung Growth at 6 Months: A Randomized Controlled Trial
@atscommunity.bsky.social #medsky
🔗 tinyurl.com/pdzbkekd
Extended Continuous Positive Airway Pressure in Preterm Infants Increases Lung Growth at 6 Months: A Randomized Controlled Trial | American Journal of Respiratory and Critical Care Medicine
tinyurl.com
January 21, 2026 at 5:27 PM
🏆 HIGHLIGHTING AJRCCM MOST-READ ARTICLES OF 2025
Extended Continuous Positive Airway Pressure in Preterm Infants Increases Lung Growth at 6 Months: A Randomized Controlled Trial
@atscommunity.bsky.social #medsky
🔗 tinyurl.com/pdzbkekd
Extended Continuous Positive Airway Pressure in Preterm Infants Increases Lung Growth at 6 Months: A Randomized Controlled Trial
@atscommunity.bsky.social #medsky
🔗 tinyurl.com/pdzbkekd
📣 Call for Papers! 📣
Looking for articles highlighting the spectrum of discovery in sleep-disordered breathing
📅 Deadline: July 1, 2026
🔬Learn More: tinyurl.com/fxsd2b9d
🖱️Submit here: tinyurl.com/3h7dmm2x
@srpatel.bsky.social @ats-srn.bsky.social @atscommunity.bsky.social #medsky
Looking for articles highlighting the spectrum of discovery in sleep-disordered breathing
📅 Deadline: July 1, 2026
🔬Learn More: tinyurl.com/fxsd2b9d
🖱️Submit here: tinyurl.com/3h7dmm2x
@srpatel.bsky.social @ats-srn.bsky.social @atscommunity.bsky.social #medsky
January 21, 2026 at 5:25 PM
📣 Call for Papers! 📣
Looking for articles highlighting the spectrum of discovery in sleep-disordered breathing
📅 Deadline: July 1, 2026
🔬Learn More: tinyurl.com/fxsd2b9d
🖱️Submit here: tinyurl.com/3h7dmm2x
@srpatel.bsky.social @ats-srn.bsky.social @atscommunity.bsky.social #medsky
Looking for articles highlighting the spectrum of discovery in sleep-disordered breathing
📅 Deadline: July 1, 2026
🔬Learn More: tinyurl.com/fxsd2b9d
🖱️Submit here: tinyurl.com/3h7dmm2x
@srpatel.bsky.social @ats-srn.bsky.social @atscommunity.bsky.social #medsky
🏆 HIGHLIGHTING AJRCCM MOST-READ ARTICLES OF 2025
Effect of Triple Therapy on Cardiovascular and Severe Cardiopulmonary Events in Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis of a Randomized, Double-Blind, Phase 3 Clinical Trial @atscommunity.bsky.social #medsky
🔗 tinyurl.com/yc3zkumw
Effect of Triple Therapy on Cardiovascular and Severe Cardiopulmonary Events in Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis of a Randomized, Double-Blind, Phase 3 Clinical Trial @atscommunity.bsky.social #medsky
🔗 tinyurl.com/yc3zkumw
Effect of Triple Therapy on Cardiovascular and Severe Cardiopulmonary Events in Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis of a Randomized, Double-Blind, Phase 3 Clinical Trial (ETHOS) | American Journal of Respiratory and Critical Care Medicine
Objectives: To assess the effects of BGF 320/18/9.6 μg (BGF 320) and other inhaled corticosteroid–containing arms on cardiovascular and severe cardiopulmonary endpoints versus GFF in patients with COPD from the ETHOS trial.
tinyurl.com
January 20, 2026 at 5:13 PM
🏆 HIGHLIGHTING AJRCCM MOST-READ ARTICLES OF 2025
Effect of Triple Therapy on Cardiovascular and Severe Cardiopulmonary Events in Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis of a Randomized, Double-Blind, Phase 3 Clinical Trial @atscommunity.bsky.social #medsky
🔗 tinyurl.com/yc3zkumw
Effect of Triple Therapy on Cardiovascular and Severe Cardiopulmonary Events in Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis of a Randomized, Double-Blind, Phase 3 Clinical Trial @atscommunity.bsky.social #medsky
🔗 tinyurl.com/yc3zkumw
🏆 HIGHLIGHTING AJRCCM MOST-READ ARTICLES OF 2025
Care of Infants and Children with Tracheostomies: An Official American Thoracic Society Clinical Practice Guideline
@atscommunity.bsky.social #medsky
🔗 tinyurl.com/bdd2ucrd
Care of Infants and Children with Tracheostomies: An Official American Thoracic Society Clinical Practice Guideline
@atscommunity.bsky.social #medsky
🔗 tinyurl.com/bdd2ucrd
Care of Infants and Children with Tracheostomies: An Official American Thoracic Society Clinical Practice Guideline | American Journal of Respiratory and Critical Care Medicine
tinyurl.com
January 19, 2026 at 7:58 PM
🏆 HIGHLIGHTING AJRCCM MOST-READ ARTICLES OF 2025
Care of Infants and Children with Tracheostomies: An Official American Thoracic Society Clinical Practice Guideline
@atscommunity.bsky.social #medsky
🔗 tinyurl.com/bdd2ucrd
Care of Infants and Children with Tracheostomies: An Official American Thoracic Society Clinical Practice Guideline
@atscommunity.bsky.social #medsky
🔗 tinyurl.com/bdd2ucrd
🏆 HIGHLIGHTING AJRCCM MOST-READ ARTICLES OF 2025
Association of Dose of Inhaled Corticosteroids and Frequency of Adverse Events
@atscommunity.bsky.social #medsky
🔗 tinyurl.com/242ahnyy
Association of Dose of Inhaled Corticosteroids and Frequency of Adverse Events
@atscommunity.bsky.social #medsky
🔗 tinyurl.com/242ahnyy
Association of Dose of Inhaled Corticosteroids and Frequency of Adverse Events | American Journal of Respiratory and Critical Care Medicine
tinyurl.com
January 16, 2026 at 4:42 PM
🏆 HIGHLIGHTING AJRCCM MOST-READ ARTICLES OF 2025
Association of Dose of Inhaled Corticosteroids and Frequency of Adverse Events
@atscommunity.bsky.social #medsky
🔗 tinyurl.com/242ahnyy
Association of Dose of Inhaled Corticosteroids and Frequency of Adverse Events
@atscommunity.bsky.social #medsky
🔗 tinyurl.com/242ahnyy
January 15, 2026 at 7:04 PM
Reposted by ATS Blue Journal
📣 Call for Papers! 📣
Looking for articles highlighting the spectrum of discovery in sleep-disordered breathing
📅 Deadline: July 1, 2026
🔬Learn More: tinyurl.com/fxsd2b9d
🖱️Submit here: tinyurl.com/3h7dmm2x
@srpatel.bsky.social @ats-srn.bsky.social @atscommunity.bsky.social #medsky
Looking for articles highlighting the spectrum of discovery in sleep-disordered breathing
📅 Deadline: July 1, 2026
🔬Learn More: tinyurl.com/fxsd2b9d
🖱️Submit here: tinyurl.com/3h7dmm2x
@srpatel.bsky.social @ats-srn.bsky.social @atscommunity.bsky.social #medsky
January 13, 2026 at 5:48 PM
📣 Call for Papers! 📣
Looking for articles highlighting the spectrum of discovery in sleep-disordered breathing
📅 Deadline: July 1, 2026
🔬Learn More: tinyurl.com/fxsd2b9d
🖱️Submit here: tinyurl.com/3h7dmm2x
@srpatel.bsky.social @ats-srn.bsky.social @atscommunity.bsky.social #medsky
Looking for articles highlighting the spectrum of discovery in sleep-disordered breathing
📅 Deadline: July 1, 2026
🔬Learn More: tinyurl.com/fxsd2b9d
🖱️Submit here: tinyurl.com/3h7dmm2x
@srpatel.bsky.social @ats-srn.bsky.social @atscommunity.bsky.social #medsky
🏆 HIGHLIGHTING AJRCCM MOST-READ ARTICLES OF 2025
Efficacy and Safety of Admilparant, an LPA1 Antagonist, in Pulmonary Fibrosis: A Phase 2 Randomized Clinical Trial
@atscommunity.bsky.social #medsky
🔗 tinyurl.com/bdyja9r2
Efficacy and Safety of Admilparant, an LPA1 Antagonist, in Pulmonary Fibrosis: A Phase 2 Randomized Clinical Trial
@atscommunity.bsky.social #medsky
🔗 tinyurl.com/bdyja9r2
Efficacy and Safety of Admilparant, an LPA1 Antagonist, in Pulmonary Fibrosis: A Phase 2 Randomized Clinical Trial | American Journal of Respiratory and Critical Care Medicine
tinyurl.com
January 15, 2026 at 6:27 PM
🏆 HIGHLIGHTING AJRCCM MOST-READ ARTICLES OF 2025
Efficacy and Safety of Admilparant, an LPA1 Antagonist, in Pulmonary Fibrosis: A Phase 2 Randomized Clinical Trial
@atscommunity.bsky.social #medsky
🔗 tinyurl.com/bdyja9r2
Efficacy and Safety of Admilparant, an LPA1 Antagonist, in Pulmonary Fibrosis: A Phase 2 Randomized Clinical Trial
@atscommunity.bsky.social #medsky
🔗 tinyurl.com/bdyja9r2
🏆 HIGHLIGHTING AJRCCM MOST-READ ARTICLES OF 2025
Evidence-based Emergency Tracheal Intubation
@atscommunity.bsky.social #medsky
🔗 tinyurl.com/2yh4632v
Evidence-based Emergency Tracheal Intubation
@atscommunity.bsky.social #medsky
🔗 tinyurl.com/2yh4632v
Evidence-based Emergency Tracheal Intubation | American Journal of Respiratory and Critical Care Medicine
tinyurl.com
January 14, 2026 at 3:22 PM
🏆 HIGHLIGHTING AJRCCM MOST-READ ARTICLES OF 2025
Evidence-based Emergency Tracheal Intubation
@atscommunity.bsky.social #medsky
🔗 tinyurl.com/2yh4632v
Evidence-based Emergency Tracheal Intubation
@atscommunity.bsky.social #medsky
🔗 tinyurl.com/2yh4632v